Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-18-035975

Options or other derivatives

  • Director acquired 68,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Jenkins John Kenneth · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-06-05 Grant or award : show line 1 in the form Stock Option(right to buy) +68,000 $6.00 2028-06-05 68,000 68,000 D
Loading xslF345X03/doc4.xml…